Do I need to take Apelvis for life? Treatment cycle and effects after discontinuation

Alpelisib is an oral PI3K inhibitor mainly used to treat HER2-negative and HR-positive breast cancer, especially for patients with advanced breast cancer who are resistant to endocrine therapy. The treatment cycle of Apelvis and whether it needs to be taken for a long time need to be evaluated based on the patient's condition, treatment response, side effects and other factors.

Apelvis does not need to be taken for life. Patients usually need to continue using the drug during the early stages of treatment, especially in patients with advanced breast cancer that is resistant to endocrine therapy. Apelvis is often combined with fulvestrant to enhance its efficacy. When patients take Apelvis, the duration of treatment usually depends on the progression of the disease. If the patient responds well after taking the medicine and has no obvious side effects, the treatment cycle can be extended. However, if the patient develops disease progression or drug resistance, doctors may consider discontinuing the drug or adjusting the treatment plan. In other words, the time of use of Apelvis is not fixed and needs to be flexibly adjusted according to the patient's individual response and changes in the condition.

During treatment with Apelvis, patients may experience relapse or worsening of symptoms after discontinuation of the drug. Apelvis controls the growth and spread of cancer cells by inhibiting the PI3K signaling pathway. After the drug is stopped, the cancer cells may become active again, causing the disease to relapse. Therefore, before stopping medication, doctors usually conduct a comprehensive assessment of the patient's condition to ensure that the patient's cancer is under control. For some patients, stopping the drug may lead to rapid disease progression, especially if other effective treatment options are not available.
Long-term use of Apelvis may cause some side effects, such as hyperglycemia, rash, gastrointestinal discomfort, etc. Patients need to regularly monitor blood sugar and liver function and other indicators during treatment. If a patient experiences serious side effects while taking the drug, the doctor may consider adjusting the dose or suspending the medication. In addition, the interaction between Apelvis and other drugs also requires special attention. Patients should inform their doctors about other drugs they are taking when taking the drug to avoid the occurrence of adverse reactions.
Reference: https://www.piqray.com/